Ding Li

Prof. Ding Li

Sun Yat-sen University, Guangzhou, Guangdong, China
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2015 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
SZShang-Shi Zhang
Shang-Shi Zhang
CJChun-Yong Jiang
Chun-Yong Jiang
JWJia-Qiang Wu
Jia-Qiang Wu
XLXu-Ge Liu
Xu-Ge Liu
QLQingjiang Li
Qingjiang Li
HWHonggen Wang
Honggen Wang
Cp*Rh(iii)- and Cp*Ir(iii)-catalysed direct C–H arylation with quinone diazides provides a facile and redox-neutral access to arylated phenols.

30 January 2018 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
BSBing Shu
Bing Shu
JCJiaojiao Cao
Jiaojiao Cao
GKGuotao Kuang
Guotao Kuang
JQJun Qiu
Jun Qiu
MZMeiling Zhang
Meiling Zhang
DLDing Li
Ding Li
We synthesized a series of acridone derivatives for specific binding ligands of i-motifs. Subsequent evaluations showed that B19 could selectively bind to and stabilize the c-myc promoter i-motif without significant binding to the G-quadruplex and duplex DNA. This caused down-regulation of c-myc transcription and expression, resulting in tumor cell apoptosis.

25 July 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
XLXiaoya Li
Xiaoya Li
JWJing Wang
Jing Wang
XGXue Gong
Xue Gong
MZMeiling Zhang
Meiling Zhang
SKShuangshuang Kang
Shuangshuang Kang
DLDing Li
Ding Li
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) are global epidemic public health problems with pathogenesis incompletely understood. Hepatocyte excessive apoptosis is a significant symbol for NAFLD/NASH patients, and therefore anti-apoptosis therapy could be used for NAFLD/NASH treatment. Up-regulation of BCL-2 has been found to be closely related with anti-apoptosis. BCL-2 gene promoter region has a C-rich sequence, which can form i-motif structure and play important role in regulating gene transcription. In this study, after extensive screening and evaluation, we found that acridone derivative A22 could up-regulate BCL-2 transcription and translation in vitro and in cells through selective binding to and stabilizing BCL-2 gene promoter i-motif. Our further experiments showed that A22 could reduce hepatocyte apoptosis in NAFLD/NASH model possibly through up-regulating BCL-2 expression. A22 could reduce inflammation, endoplasmic reticulum stress and cirrhosis in high-fat diet-fed mice liver model. Our findings provide a potentially new approach of anti-apoptosis for NAFLD/NASH treatment, and A22 could be further developed as a lead compound for NAFLD/NASH therapy. Our present study first demonstrated that gene promoter i-motif could be targeted for gene up-regulation for extended treatment of other important diseases besides cancer.

22 July 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CWChen-Xi Wang
Chen-Xi Wang
ZZZi-Lin Zhang
Zi-Lin Zhang
QYQi-Kun Yin
Qi-Kun Yin
JTJia-Li Tu
Jia-Li Tu
JWJia-En Wang
Jia-En Wang
ZHZhi-Shu Huang
Zhi-Shu Huang

2 March 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
QYQi-Kun Yin
Qi-Kun Yin
CWChen-Xi Wang
Chen-Xi Wang
YWYu-Qing Wang
Yu-Qing Wang
QGQian-Liang Guo
Qian-Liang Guo
ZZZi-Lin Zhang
Zi-Lin Zhang
ZHZhi-Shu Huang
Zhi-Shu Huang

12 August 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GKGuo-Tao Kuang
Guo-Tao Kuang
MZMeiling Zhang
Meiling Zhang
SKShuangshuang Kang
Shuangshuang Kang
DHDexuan Hu
Dexuan Hu
XLXiaoya Li
Xiaoya Li
DLDing Li
Ding Li